Literature DB >> 12691531

Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells.

Makoto Miyagishi1, Mariko Hayashi, Kazunari Taira.   

Abstract

RNA interference appears to be a potentially powerful tool for studies of genes of unknown function. However, differences in efficacy at different target sites remain problematic when small interfering RNA (siRNA) is used as an effector. Similar problems are associated with attempts at gene inactivation using antisense oligonucleotides (ODNs) and ribozymes. We performed a comparative analysis of the suppressive effects of three knockdown methods, namely, methods based on RNA interference (RNAi), antisense ODNs, and ribozymes, using a luciferase reporter system. Dose-response experiments revealed that the IC50 value for the siRNA was about 100-fold lower than that of the antisense ODN. Our results provide useful information about the positional effects in RNAi, which might help to improve the design of effective siRNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691531     DOI: 10.1089/108729003764097296

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  34 in total

1.  The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.

Authors:  Rosel Kretschmer-Kazemi Far; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA.

Authors:  Petr Pancoska; Zdenek Moravek; Ute M Moll
Journal:  Nucleic Acids Res       Date:  2004-03-01       Impact factor: 16.971

Review 3.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

4.  Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.

Authors:  Jorge F Coelho; Paula C Ferreira; Patricia Alves; Rosemeyre Cordeiro; Ana C Fonseca; Joana R Góis; Maria H Gil
Journal:  EPMA J       Date:  2010-04-10       Impact factor: 6.543

5.  REM sleep changes in rats induced by siRNA-mediated orexin knockdown.

Authors:  Lichao Chen; Mahesh M Thakkar; Stuart Winston; Yunren Bolortuya; Radhika Basheer; Robert W McCarley
Journal:  Eur J Neurosci       Date:  2006-10       Impact factor: 3.386

6.  Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi.

Authors:  Benoit Bilanges; David Stokoe
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

7.  Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.

Authors:  Long Sheng; Maoming Xiong; Cong Li; Xiangling Meng
Journal:  Pathol Oncol Res       Date:  2013-12-11       Impact factor: 3.201

8.  Therapeutic potential of RNA interference in pain medicine.

Authors:  Ping-Heng Tan; Lin-Cheng Yang; Ru-Rong Ji
Journal:  Open Pain J       Date:  2009-01-01

9.  Comparing 2-nt 3' overhangs against blunt-ended siRNAs: a systems biology based study.

Authors:  Preetam Ghosh; Robert Dullea; James E Fischer; Tom G Turi; Ronald W Sarver; Chaoyang Zhang; Kalyan Basu; Sajal K Das; Bradley W Poland
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

10.  Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.

Authors:  Hongyan Wang; Animesh Ghosh; Huricha Baigude; Chao-Shun Yang; Linghua Qiu; Xugang Xia; Hongxia Zhou; Tariq M Rana; Zuoshang Xu
Journal:  J Biol Chem       Date:  2008-03-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.